E-LIB Suche - Ergebnisse für: Thatcher, Nick

1

Defining Aggressive Or Early Progressing Nononcogene-Addict..:

Reck, Martin ; Kerr, Keith M ; Grohé, Christian...
Future Oncology. 15 (2019) 12 - p. 1363-1383 , 2019

Link: https://doi.org/10.2217/..

2

Totality of evidence in the development of ABP 215, an appr..:

Thomas, Michael ; Thatcher, Nick ; Goldschmidt, Jerome...
Immunotherapy. 11 (2019) 15 - p. 1337-1351 , 2019

Link: https://doi.org/10.2217/..

3

Venous thromboembolism with EGFR monoclonal antibody necitu..:

Young, Kelvin ; Paz-Ares, Luis ; Thatcher, Nick...
Thrombosis Research. 167 (2018) - p. 50-56 , 2018

Link: https://doi.org/10.1016/..

4

Efficacy and Safety of Necitumumab Continuation Therapy in ..:

Ciuleanu, Tudor ; Socinski, Mark A. ; Obasaju, Coleman...
Clinical Lung Cancer. 19 (2018) 2 - p. 130-138.e2 , 2018

Link: https://doi.org/10.1016/..

5

Current and Emergent Therapy Options for Advanced Squamous ..:

Socinski, Mark A. ; Obasaju, Coleman ; Gandara, David...
Journal of Thoracic Oncology. 13 (2018) 2 - p. 165-183 , 2018

Link: https://doi.org/10.1016/..

6

Molecular and Immune Biomarker Testing in Squamous-Cell Lun..:

Hirsch, Fred R. ; Kerr, Keith M. ; Bunn Jr., Paul A....
Clinical Lung Cancer. 19 (2018) 4 - p. 331-339 , 2018

Link: https://doi.org/10.1016/..

7

P2.03b-035 EGFR FISH as Potential Predictor of Necitumumab ..:

Genova, Carlo ; Varella-Garcia, Marileila ; Rivard, Christopher...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S955-S956 , 2017

Link: https://doi.org/10.1016/..

8

P2.03a-025 Randomized, Double-Blind, Phase 3 Study Comparin..:

Thatcher, Nick ; Thomas, Michael ; Ostoros, Gyula...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S902-S903 , 2017

Link: https://doi.org/10.1016/..

9

OA23.02 Efficacy and Safety of Necitumumab Continuation Mon..:

Ciuleanu, Tudor ; Socinski, Mark ; Obasaju, Coleman...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S334 , 2017

Link: https://doi.org/10.1016/..

10

Clinicopathologic Features of Advanced Squamous NSCLC:

Socinski, Mark A. ; Obasaju, Coleman ; Gandara, David...
Journal of Thoracic Oncology. 11 (2016) 9 - p. 1411-1422 , 2016

Link: https://doi.org/10.1016/..

11

Necitumumab plus Gemcitabine and Cisplatin as First-Line Th..:

Reck, Martin ; Thomas, Michael ; Kropf-Sanchen, Cornelia...
Oncology Research and Treatment. 39 (2016) 9 - p. 539-547 , 2016

Link: https://doi.org/10.1159/..

12

The Effect of Necitumumab in Combination with Gemcitabine p..:

Reck, Martin ; Socinski, Mark A. ; Luft, Alexander...
Journal of Thoracic Oncology. 11 (2016) 6 - p. 808-818 , 2016

Link: https://doi.org/10.1016/..

13

Meta-analysis of individual patient data from randomized tr..:

Pujol, Jean-Louis ; Pirker, Robert ; Lynch, Thomas J....
Lung Cancer. 83 (2014) 2 - p. 211-218 , 2014

Link: https://doi.org/10.1016/..

14

The impact on the multidisciplinary team of molecular profi..:

Blackhall, Fiona ; Thatcher, Nick ; Booton, Richard.
Lung Cancer. 79 (2013) 2 - p. 101-103 , 2013

Link: https://doi.org/10.1016/..

15

ALK translocation and crizotinib in non-small cell lung can..:

Scagliotti, Giorgio ; Stahel, Rolf A. ; Rosell, Rafael..
European Journal of Cancer. 48 (2012) 7 - p. 961-973 , 2012

Link: https://doi.org/10.1016/..